Moderna Inc. buy UBS Group AG
Start price
07.05.24
/
50%
€110.94
Target price
07.05.25
€140.14
Performance (%)
-80.76%
End price
08.05.25
€21.34
Summary
This prediction ended on 08.05.25 with a price of €21.34. The BUY prediction by UBS_Group_AG for Moderna Inc. performed very badly with a performance of -80.76%. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 5.921% | 5.921% | 109.783% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at UBS Group AG from $143.00 to $151.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten